Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

被引：0
作者：
Dimitrios Mathios
Jacob Ruzevick
Christopher M. Jackson
Haiying Xu
Sagar R. Shah
Janis M. Taube
Peter C. Burger
Edward F. McCarthy
Alfredo Quinones-Hinojosa
Drew M. Pardoll
Michael Lim
机构：
[1] The Johns Hopkins University School of Medicine,Department of Neurosurgery
[2] The Johns Hopkins University School of Medicine,Department of Dermatology
[3] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[4] The Johns Hopkins University School of Medicine,Department of Pathology
[5] The Johns Hopkins University School of Medicine,Department of Oncology
[6] The Johns Hopkins University School of Medicine,Department of Medicine
[7] Johns Hopkins Hospital,Department of Neurosurgery
来源：
Journal of Neuro-Oncology | 2016年 / 128卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 183
相关论文
共 50 条
[31]   Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma [J].
Lee, Min Young ;
Park, Chan-jeoung ;
Cho, Young-Uk ;
You, Eunkyoung ;
Jang, Seongsoo ;
Lee, Jung-Hee ;
Hong, Jung Yong ;
Yoon, Dok Hyun ;
Suh, Cheolwon .
BLOOD, 2017, 130
[32]   Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer [J].
Yusof, Mohd Nazzary Mamat ;
Chew, Kah Teik ;
Kampan, Nirmala Chandralega ;
Hafizz, Abdul Muzhill Hannaan Abdul ;
Shafiee, Mohamad Nasir .
PLOS ONE, 2025, 20 (03)
[33]   Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis [J].
Suszczyk, Dorota ;
Skiba, Wiktoria ;
Zardzewialy, Witold ;
Pawlowska, Anna ;
Wlodarczyk, Karolina ;
Polak, Grzegorz ;
Tarkowski, Rafal ;
Wertel, Iwona .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
[34]   Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer [J].
Jiang, Siqing ;
Li, Xin ;
Huang, Lihua ;
Xu, Zhensheng ;
Lin, Jinguan .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[35]   Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2 [J].
Zak, Krzysztof M. ;
Grudnik, Przemyslaw ;
Magiera, Katarzyna ;
Domling, Alexander ;
Dubin, Grzegorz ;
Holak, Tad A. .
STRUCTURE, 2017, 25 (08) :1163-1174
[36]   High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2 [J].
Li, Yanyan ;
Liang, Zhaoduan ;
Tian, Ye ;
Cai, Wenxuan ;
Weng, Zhiming ;
Chen, Lin ;
Zhang, Huanling ;
Bao, Yifeng ;
Zheng, Hongjun ;
Zeng, Sihai ;
Bei, Chunhua ;
Li, Yi .
CANCER SCIENCE, 2018, 109 (08) :2435-2445
[37]   Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade [J].
Bai, Jie ;
Gao, Zhitao ;
Li, Xiang ;
Dong, Liang ;
Han, Weidong ;
Nie, Jing .
ONCOTARGET, 2017, 8 (66) :110693-110707
[38]   The role of antagonists of the PD-1: PD-L1/PD-L2 axis in head and neck cancer treatment [J].
Pai, Sara I. ;
Zandberg, Dan P. ;
Strome, Scott E. .
ORAL ONCOLOGY, 2016, 61 :152-158
[39]   Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus [J].
Costa, Nadia Lago ;
Goncalves, Julie Ane Maria ;
de Lima, Sara Lia Goncalves ;
de Arruda, Jose Alcides Almeida ;
Miranda, Ana Carolina Campos ;
Mesquita, Ricardo Alves ;
da Silveira, Ericka Janine Dantas ;
Batista, Aline Carvalho .
ORAL DISEASES, 2020, 26 (06) :1246-1254
[40]   Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2 [J].
Spirina, Liudmila ;
Yurmazov, Zahar ;
Usynin, Evgeny ;
Kondakova, Irina ;
Ladutko, Ekaterine ;
Choynzonov, Evgeny .
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) :1072-1080
12345